Ceapro Stock

Ceapro OCF Margin

Delisted

The Operating Cash Flow Margin of Ceapro (CZO.V) as of Jul 28, 2026 is -37.61 %. In the previous year, Operating Cash Flow Margin was 35.23 % — a change of -206.76% (lower).

OCF Margin

-37.61 %

YoY

-206.76%

Last updated:

Operating Cash Flow Margin of Ceapro is 2026 -37.61 % . Operating Cash Flow Margin of Ceapro was 2025 35.23 % . It decreases by -206.76% lower compared to the previous year.
Access this data via the Eulerpool API

Ceapro Stock analysis

What does Ceapro do? Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ceapro stock

Operating Cash Flow Margin of Ceapro is -37.61 % in 2026.

Access this data via the Eulerpool API

Margins — Ceapro

All Key Metrics — Ceapro